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Crystalline lastase 1 from human pancreas was digested with trypsin. Two peptides, containing the potential N-glycosyla- 
tion sites at Ash-86 and Asn-125, were isolated and analyzed by amino acid analysis, sequencing and carbohydrate com- 
ponent analysis. The results demonstrate that only Asn-86 is glycosylated. 
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1. INTRODUCTION 2. MATERIALS AND METHODS 
Human pancreatic elastase 1(El), a member of 
an acidic elastase family [I], was found to associate 
with bile acids and cholesterol [2], a unique func- 
tion which may be significant in cholesterol 
metabolism. To gain insight into this function and 
to compare E1 with elastase isoenzymes, which 
have recently been sequenced after gene cloning 
[3,4], we are studying the structure of El, a glyco- 
protein [2,5]. We report here the partial sequence 
analysis of El, confirming the two potential N- 
glycosylation sites which are also present in the se- 
quence of protease E [3] and elastase III [4], the 
assignment ofthe oligosaccharide to a specific pep- 
tide sequence and analysis of the components of 
the carbohydrate moiety. 
2.1. Preparation and crystallization fE1 
As detailed [2], El was purified to homogeneity from human 
necrobiotic pancreas tissue and crystallized by dialyzing the en- 
zyme vs bidistilled water at 4°C. 
2.2. Proteolysis 
To prevent autodigestion, E1 (2-5 rag) was incubated for 
5 min at 95°C in 0.1 M Tris-HC1 (pH 8.3), containing 1mM 
EDTA and 6 M guanidine hydrochloride, being deaerated with 
N2. Dithiothreitol was added to a final concentration f 2 mM 
and the solution was incubated for 90 min at 37°C in the dark. 
Iodoacetic acid, neutralized with NaOH, was added to a final 
concentration f 5 raM. After incubation for 1 h at 37°C in the 
dark, mercaptoethanol (1%, v/v) was added and the solution 
dialyzed exhaustively against distilled water. Reduced and car- 
boxymethylated El was digested with TPCK-treated trypsin 
(Serva, Heidelberg) (1:50, w/w) for 3 h at 37°C in 0.1 M 
NI-I4HCO3 buffer (pH 8.2). For subfractionation, tryptic pep- 
tides (0.5-2 mg) were further digested with endoproteinase Asp- 
N (Boehringer, Mannheim) (1:200, w/w, 18 h, 37°C, 50 mM 
sodium phosphate buffer; pH 8.0). 
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2.3. Fractionation of (glyco)peptides 
Tryptic digests were fractionated using gel-permeation 
chromatography followed by rHPLC [6]. Peak fractions were 
collected as recorded by continuous flow monitoring of the ab- 
sorbance at 220 nm. 
2.4. Protein analytical methods 
The amino acid (or hexosamine) composition of (glyco)pep- 
tides was determined using a Biotronik (Frankfurt) model LC 
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6001 analyzer after 24 h (or 2 h) of hydrolysis at 110°C (or 
100°C) in 6 N (or 4 N) aqueous HC1 using o-phthaldialdehyde 
as colouring reagent. Amino acid sequence analysis of the 
(glyco)peptides (each 30-50 nmol) was performed on a mode/ 
Mini 15 (Sequemat; Watertown, MA) solid-phase sequencer 
resulting in repetitive yields of 75 + 10070 after coupling of pep- 
tides to aminopropyl glass with 1-ethyl-3-dimethylaminopropyl- 
carbodiimide (both Pierce, Rockford, IL) [7]. PTH-amino acids 
were identified by rHPLC [8] using Gynkotek (Miinchen) equip- 
ment (including amodel SP-6A absorbance detector) coupled to 
a Shimadzu CR-3A integrator. 
2.5. Carbohydrate analytical methods 
The mixture of alditol acetates obtained after hydrolysis of 
glycopeptides was analyzed by capillary gas liquid 
chromatography-mass fragmentography as in [9,10]. 
2.6. Deglycosylation f glycopeptides 
Glycopeptides were deglycosylated by treatment with pep- 
tide:N-glycosidase F (Boehringer) as described [11]. 
3. RESULTS 
Gel-permeation chromatography of the tryptic 
digest of E1 is depicted in fig.1. Fractions were 
analyzed for glycopeptides by determination of 
hexosamines after hydrolysis, combined as in- 
dicated (A,B) and subjected to rHPLC (fig.2). 
Glycopeptides were monitored as described above, 
each peak fraction being subjected to amino acid 
analysis (table 1). Those having identical amino 
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Fig.l .  Gel permeation chromatography of carboxymethylated 
E1 after digestion with trypsin. Column, TSK HW-40 S (Merck, 
Darmstadt, FRG), 15 × 900 mm; buffer, 25 mM ammonium 
acetate (pH 6.0) containing 0.2 g/l NAN3; flow rate, 18 ml/h at 
25°C. The elution profile was recorded by continuous flow 
monitoring of the absorbance at 228 nm. Glycopeptide frac- 
tions according to their hexosamine content were combined as 
indicated (A,B). Pool C contains peptide $2 (M, = 3600) with 
the potential glycosylation site at Asn-125. 
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Fig.2. Isolation of El (glyco)peptides from fractions A-C (see 
fig.l) by rHPLC on a 3/~m ODS column (Shandon, Astmoor, 
UK) (0.46 x 25 cm). A linear gradient of acetonitrile in 25 mM 
ammonium acetate buffer (pH 6) was applied. Only the hatched 
fractions contain glucosamine. The pure (glyco)peptides were 
identified by amino acid analysis and solid-phase sequencing 
before and after subfractionation by endoproteinase Asp-N (see 
fig.3). 
acid composition were combined (fig.2, hatched 
peaks) and further characterized by end-group 
determination and partial solid-phase peptide se- 
quencing. 
Comparison of our analytical data with the 
amino acid sequence of elastase IIIb published by 
Tani et al. [4] allowed identification and assign- 
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Table 1 
Amino acid analysis of tryptic (glyco)peptides from elastase 1
containing potential N-glycosylation sites (s) 
Amino acid Composition a 
Sl.1 (Glu) b S1.2 (Glu) b $2 (Ser) b 
Cysc ( 2 ) 2.2 ( - ) - ( 1 ) 1.3 
Asx ( 5 ) 4.9 ( 3 ) 2.7 ( 3 ) 2.7 
Thr a - - ( - )  - (2 )  1.6 
Ser a ( 2 ) 1.7 ( 1 ) 0.8 ( 2 ) 1.9 
Glx ( 3 ) 3.8 ( 3 ) 2.7 ( 3 ) 3.5 
Gly (3 )  2.9 (2 )  2.3 (4 )  3.6 
Ala (2 )  2 ( - )  - (4 )  3.8 
Val (3 )  2.5 (2 )  1.1 (1 )  1.0 
Met ( - )  - ( - )  - ( - )  - 
lie (4 )  3.2 (2 )  1.1 (2 )  1.9 
Leu (3 )  3 (2 )  1.8 (4 )  5.2 
Tyr ( - )  - ( - )  - ( 1 ) 1.1 
Phe (1 )  0.9 (1 )  0.8 ( - )  - 
His ( 1 ) 0.8 ( 1 ) 1 ( - )  - 
Lys ( 1 ) 0.8 ( - )  - ( - )  - 
Arg ( 1 ) 1.0 ~ ( 1 ) 1.0 c ( 1 ) 1,0 e 
Trp f ( 1 ) + ( 1 ) + ( 1 ) + 
Pro g (3 )  (3 )  (4 )  
GlcNAc f + + - 
a Molar ratios of amino acids; data expected from the sequence 
of elastase I l lb [4] are given in parentheses, b NH2-terminal 
amino acid determined by dansylation, c Determined as car- 
boxymethylcysteine, d Data not corrected, e Based on Arg = 1. 
f Not quantified, gNot determined 
ment of the E 1 glycopeptides. Using this approach, 
two homogeneous glycopeptides could be iden- 
tified. The first (SI.1) represents the peptide 
Glu-66...Lys-100, which was not cleaved by trypsin 
after Arg-87, the second (S1.2) corresponding to 
the peptide Glu-66...Arg-87. For further 
characterization of these fragments, they were 
deglycosylated by peptide:N-glycosidase F which 
cleaves N-glycosidically bound oligosaccharides 
leaving Asp residues in the polypeptide chain. 
Component analysis of the carbohydrate moieties 
revealed that both glycopeptides of E1 contain 
Fuc, Man, Gal, GlcNAc and GalNAc in the molar 
ratio of 1.5 • 3.0: 2.0: 5.0: 0.4. The deglycosylated 
peptides were subfragmented by endoproteinase 
Asp-N to obtain smaller peptides (S1P1-S1P4) 
because sequencing of S1 stopped at step 20 
(Trp-85). Within peptide $2 (see fig.2C), contain- 
ing the second potential glycosylation site at 
Asn-125, no hexosamines could be detected on 
amino acid analysis (table 1) and sequencing of 
peptide $2P3 shows that no oligosaccharide bound 
at Asn-125. The sequencing results are summarized 
in fig.3. 
Beside peptides S1 and $2, we partially se- 
quenced other parts of El, namely Val-1...Ser-11; 
Ser-104...Arg-136; Lys-137...Tyr-157; Thr-173... 
Arg-182; Ser-183...Gly-191; Val-228...Ser-241. No 
difference in these amino acid sequences v  elastase 
IIIb was detected. 
4. DISCUSSION 
E1 described here was originally detected in 
human intestinal fluids through its capacity for 
binding to cholesterol and deoxycholate [2] and 
shown to be immunologicaUy identical with 
elastase 1, isolated by Largman et al. [12]. Our 
structural studies now confirm that this enzyme is 
basically identical to elastase IIIb, investigated by 
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Fig.3. Amino acid sequence of tryptic peptides of El containing potential N-glycosylation sites (boxes) according to [4]. Isolated tryptic 
and endoproteinase Asp-N peptides are underlined. Amino acids determined via solid-phase sequencing are designated by (--,), and those 
deduced from amino acid analysis by (+). N-glycosidically bound oligosaccharides (CHO). (*) After deglycosylation f peptide S 1 with 
peptide:N-glycosidase F, PTH-Asp is found in S1P3. 
277 
Volume 249, number 2 FEBS LETTERS June 1989 
Tani et al. [4], To date, no results have been 
reported about  the extent of  glycosylat ion o f  this 
enzyme. Here, we have shown that only one of  the 
potent ia l  N-glycosylat ion sites of  E1 is 
glycosylated. Apar t  f rom the digestive funct ion of  
E 1, the enzyme may play an important  role in the 
intraintest inal  t ransport  o f  cholesterol,  a process 
upon which we now focus further attent ion.  A pre- 
requisite for this funct ion is that E1 survives in- 
testinal passage. Glycosylat ion could be responsi- 
ble for protect ing E1 against proteolyt ic attack in 
the intestine. Structural  elucidat ion of  the ol igosac- 
charides may also contr ibute to a better classifica- 
t ion of  elastase isoenzymes. 
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